cemka > Publications > Infectiologie

Classer les publications sur l'année

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.

    WEIL-OLIVIER C, TAHA MK, BOUEE S, EMERY C, LONCLE-PROVOT V, NACHBAUR G, BECK E, PRIBIL C.

    Human Vaccines & Immunotherapeutics ; 2022;18(1):2021764

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Correction to: Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM)

    SHEN J, BOUEE S, ARIS E, EMERY C, BECK EC.

    Infect Dis Ther ; 2022;11(1):263-264

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database

    TAHA M.-K , WEIL-OLIVIER C , BOUEE S, EMERY C , NACHBAUR G, PRIBIL C, LONCLE-PROVOT V.

    HUMAN VACCINES & IMMUNOTHERAPEUTICS ; 2021;17(6):1858-1866

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database

    WEIL-OLIVIER C, TAHA M-K, EMERY C, BOUEE S, BECK E, ARIS E, LONCLE-PROVOT V, NACHBAUR G, PRIBIL C.

    Infectious Diseases and Therapy ; 2021;10(3):1607-1623

  • Pharmaco-EpidĂ©miologie

    Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study

    BARBUT F, DAY N, BOUÉE S, YOUSSOUF A, GRANDVOINNET L, LALANDE V, COUTURIER J, ECKERT C

    Clin Microbiol Infect ; 2019;25(5):588-594

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database

    TAHA M.-K , WEIL-OLIVIER C , BOUEE S, EMERY C , NACHBAUR G, PRIBIL C, LONCLE-PROVOT V.

    HUMAN VACCINES & IMMUNOTHERAPEUTICS ; 2021;17(6):1858-1866

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France

    POURCHER V, GOURMELEN J, BUREAU I, BOUEE S

    PLOS ONE ; 2020;15(12),e0243529

  • Pharmaco-EpidĂ©miologie

    Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study

    DINH A, LE MONNIER A, EMERY C, ALAMI S, TORRETON É, DUBURCQ A, BARBIER F.

    Eur J Clin Microbiol Infect Dis ; 2019;38(7):1297-1305

  • Pharmaco-EpidĂ©miologie

    Estimation de l’incidence des infections Ă  papillomavirus en France

    DETOURNAY B, GRANADOS-CANAL D, EL HASNAOUI A

    Gynécol Obstét Fertil ; 37:125-130

  • Pharmaco-EpidĂ©miologie

    Impact sur la fonction rĂ©nale d’un relais prĂ©coce de la formulation conventionnelle de l’amphotĂ©ricine B par sa formulation liposomale dans le cadre d’un traitement empirique antifongique (Etude Nephemat)

    ISNARD F, TILLEUL P, LAPORTE JF, CHEVALLIER P, PIGNEUX A, LAFUMA A, MONCHECOURT F, MAHI L, DERAY G

    Med Mal Infect ; 38(4):208-214

  • Pharmaco-EpidĂ©miologie

    Cutaneous Infrared Thermometry for Detecting Febrile Patients

    HAUSFATER P, ZHAO Y, DEFRENNE S, BONNET P, RIOU B

    Emerg Infect Dis ; 14(8):1255-1258

  • Économie de la santĂ©

    Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France

    STANDAERT B, PAREZ N, TEHARD B, COLIN X, DETOURNAY B

    Appl Health Econ Health Policy ; 6(4):199-216

  • Pharmaco-EpidĂ©miologie

    A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment

    ISNARD F, TILLEUL P, LAPORTE JF, CHEVALLIER P, PIGNEUX A, LAFUMA A, MAHI L, DERAY G

    Nephrol Dial Transplant ; 22(10):3090-3091

  • Pharmaco-EpidĂ©miologie

    StratĂ©gie diagnostique de l’infection par le VHC en mĂ©decine gĂ©nĂ©rale : Etats des lieux, nature des obstacles rencontrĂ©s – Etude GYMKHANA 1 (2Ăšme partie)

    AUBERT JP, BOUEE S, BENTATA M, COMPAGNON M, ELGHOZI B, LIVROZET JM, MECHALI D, PERDRIEAU F, PY AM, ROZEMBAUM W, TAULERA O, WAJSBROT A

    Rev Prat - Médecine Générale ; 20(726/727):386-391

  • Pharmaco-EpidĂ©miologie

    Seroprevalence of Varicella in the French Population

    KHOSHNOOD B, DEBRUYNE M, LANCON F, EMERY C, FAGNANI F, DURAND I, FLORET D

    Pediatr Infect Dis J ; 25(1):41-44